For the quarter ending September 30, Inovio reported a loss of $0.89 per share, beating analyst estimates of a $1.15 loss per share, according to Stocktwits data.
INO earnings call for the period ending September 30, 2024.
Retail sentiment on the stock dipped to ‘bullish’ from ‘extremely bullish’ last week.
Less stringent requirements in pharmaceuticals and biotechnology could help biotechs by prompting accelerated drug approvals.
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END
INO earnings call for the period ending June 30, 2024.
As a part of the annual Russell index rebalancing, here are five stocks set to join the Russell Microcap Index this year, which analysts have tagged with consensus ‘buy’ ratings.